Abstracts and Awards – BCVS Scientific Sessions 2025

Abstract submission for #BCVS25 is now closed.


Cardiac Regeneration, Stem Cells and Tissue Engineering

Cardio-immunology and Inflammation

Cardio-oncology

Cardiovascular Technologies and Therapeutics

Cell Death Mechanisms, Apoptosis, Necrosis and Autophagy

Clinical/Translational Research

COVID 19 in the Cardiovascular System

Excitation-Contraction Coupling, Ion Channels and Arrhythmias

Extracellular Vesicles and Exosome Biology

Genetics and Genomics of Cardiovascular Disease

Human Cellular Models of Disease

Inflammation, Thrombosis and Vascular Biology

Mechanisms of Cardiac Remodeling, Hypertrophy and Failure

Mechanisms of Heart Failure Preserved Ejection Fraction

Mechanisms of Myocardial Fibrosis

Mitochondria and Metabolism

Myocardial Ischemia, Oxidative Stress, and Cardioprotection

RNA in Cellular Regulation and Therapeutic Innovation

Sarcomeric Function and Contractility

Sex-based Differences in Heart Disease

Signal Transduction Pathways

Systems Approach to Cardiovascular Biology

Transcriptional and Epigenetic Regulation of Gene Expression

Cardiovascular Development and Congenital Heart Disease

Gene Expression Control: Transcriptional and Epigenetic Insights (NEW!)

Interorgan Links in Cardiovascular Disease

Non-left Ventricle Cardiac Domains in Health and Disease (NEW!)


The suggestions below are intended to provide guidance on abstract writing.

Title
To the extent the data permits, make the title dynamic and conclusive, rather than descriptive. For example, “Hypoxia Inhibits Kv1.5 Channels in Rat Pulmonary Artery Smooth Muscle Cells” is preferable to “Effects of Hypoxia on Kv1.5 Channels.” Explicit titles denoting the findings should be used (not “Investigations of…,” “Studies of…,” etc.)

Structure
Abstracts may have the following identifiable sections, but they are not mandatory: Introduction, Hypothesis, Methods, Results and Conclusions.

Abbreviations
Abbreviations may be used after they are spelled out or defined. Use generic, not commercial, names for all therapeutic agents.

Category
Be sure to select up to three abstract categories that best describes your work. Category selection determines which team grades the abstract. If you select the appropriate category, your abstract will be blindly graded by experts familiar with the science of the category.

Common mistakes

  1. Failure to state the hypothesis. We advise a formal statement such as, “We assessed the hypothesis that…”
  2. Failure to state a conclusion. We encourage a final sentence that says: “In conclusion…”
  3. Failure to state sample size. The reviewers want to assess the quality of the data – they need a mean SEM and a sample size.
  4. Excessive use of abbreviations. All but the most standard abbreviations should be defined, and most abstracts should have less than 3 abbreviations.

Traps to avoid

  1. Typographical errors
  2. References cited in the abstract
  3. Not providing context or a statement of relevance that provides the rationale for your study.
  4. Complex graphics. Simple line or bar graphs are most appropriate. Ensure the font size is adequately large on each axis to be visible. Check a printed version of the abstract before submitting.
  5. Duplicative work

Remember: Make sure your abstract is clear, concise, and follows all rules. Show your abstract to a colleague prior to submission and modify accordingly. A fresh pair of eyes will help spot any errors and will ensure the final package is ready for submission.